Efficient Nuclear Delivery and Nuclear Body Localization of Antisense Oligo-Nucleotides using Degradable Polymersomes by Kim, Younghoon et al.
University of Pennsylvania
ScholarlyCommons
Departmental Papers (CBE) Department of Chemical & BiomolecularEngineering
August 2006
Efficient Nuclear Delivery and Nuclear Body
Localization of Antisense Oligo-Nucleotides using
Degradable Polymersomes
Younghoon Kim
University of Pennsylvania
Manu Tewari
University of Pennsylvania
J. David Pajerowski
University of Pennsylvania
Shamik Sen
University of Pennsylvania
Williams Jason
Drexel University
See next page for additional authors
Follow this and additional works at: http://repository.upenn.edu/cbe_papers
Copyright 2006 IEEE. Reprinted from Proceedings of the 28th IEEE EMBS Annual International Conference, August 2006, pages 4350-4353.
This material is posted here with permission of the IEEE. Such permission of the IEEE does not in any way imply IEEE endorsement of any of the
University of Pennsylvania's products or services. Internal or personal use of this material is permitted. However, permission to reprint/republish this
material for advertising or promotional purposes or for creating new collective works for resale or redistribution must be obtained from the IEEE by
writing to pubs-permissions@ieee.org. By choosing to view this document, you agree to all provisions of the copyright laws protecting it.
This paper is posted at ScholarlyCommons. http://repository.upenn.edu/cbe_papers/112
For more information, please contact libraryrepository@pobox.upenn.edu.
Recommended Citation
Kim, Y., Tewari, M., Pajerowski, J. D., Sen, S., Jason, W., Sirsi, S., Lutz, G., & Discher, D. E. (2006). Efficient Nuclear Delivery and
Nuclear Body Localization of Antisense Oligo-Nucleotides using Degradable Polymersomes. Retrieved from
http://repository.upenn.edu/cbe_papers/112
Efficient Nuclear Delivery and Nuclear Body Localization of Antisense
Oligo-Nucleotides using Degradable Polymersomes
Abstract
Delivery of antisense oligonucleotides, AON, presents many of the same challenges as delivery of any nucleic
acid: charge, stability, cell uptake, endolysosomal escape, and entry into the nucleus. Here we demonstrate
efficient delivery of AON after loading into biodegradable polymer vesicles or 'polymersomes'. We focus on
AON delivery to muscle cells in vitro and in vivo because of the emergence of AON in therapeutic strategies
directed at muscular dystrophies. To first clarify uptake kinetics without the complications of typical multi-
layered myotube cultures, we use micro-patterned C2C12 cells and show efficient uptake of AON-
polymersomes. The biodegradable polymersomes break down and foster AON escape with the binding of
fluorescent-AON into the nuclear bodies. Intramuscular injections of the polymersome-AON into the hind
limbs of mdx-dystrophic mice show more efficient nuclear uptake than AON alone and also lead to dystrophin
expression in the mdx mice. In sum, these neutral, degradable carriers of AON show promise in vivo.
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Abstract— Delivery of antisense oligonucleotides, AON, 
presents many of the same challenges as delivery of any nucleic 
acid: charge, stability, cell uptake, endolysosomal escape, and 
entry into the nucleus.  Here we demonstrate efficient delivery 
of AON after loading into biodegradable polymer vesicles or 
‘polymersomes’.  We focus on AON delivery to muscle cells in 
vitro and in vivo because of the emergence of AON in 
therapeutic strategies directed at muscular dystrophies. To first 
clarify uptake kinetics without the complications of typical 
multi-layered myotube cultures, we use micro-patterned C2C12 
cells and show efficient uptake of AON-polymersomes.  The 
biodegradable polymersomes break down and foster AON 
escape with the binding of fluorescent-AON into the nuclear 
bodies. Intramuscular injections of the polymersome-AON into 
the hind limbs of mdx-dystrophic mice show more efficient 
nuclear uptake than AON alone and also lead to dystrophin 
expression in the mdx mice.  In sum, these neutral, degradable 
carriers of AON show promise in vivo. 
I. INTRODUCTION 
ynthetic vesicles by polyethylene oxide-polybutadiene 
(PEO-PBD) or polyethylene oxide-polycaprolactone 
(PEO-PCL) have advantages 1) carriers are so inert that it 
does not cause inflammation 2) they are so stealthy that they 
can circulate in vivo for long time, compared to cationic 
carriers and lipid vesicles [1-5]. Programmable release of 
encapsulants by controlling the ratio of 
PEO-PBD/PEO-polyesters would be another advantage [6, 
7]. Recently, endosomal release mechanism was elucidated 
by computer simulation by F.Ahmed [8].  
 
Antisense oligonucleotides (AON) are being increasingly 
used to work around deleterious mutations and/or deletions, 
including the dystrophin gene that leads to muscular 
dystrophy.  The significant advantage of AONs is the ability 
to target the gene irrespective of its large size and clinical 
applicability as small-molecule based therapy [9].  However, 
efficient delivery of AONs in muscles is a great challenge and 
much depends on the carriers that provide protection against 
degradation, cell specificity and release [10-12].  
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Here we detail the AON delivery by controlled-release 
polymersomes. AON was encapsulated within 
PBO-PBD/PEO-PCL blend vesicles for programmable 
release. The AON delivery into muscle cells for corrective 
therapy depends much upon the delivery system that provides 
advantages of site-specific delivery, protection from 
nucleases and tailored release. PEGylated micelles or 
polymersomes have nontoxic, inert properties and cells can 
take them up to be transported perinucleus region without any 
further modification [13]. 6-fem (green) labeled AON and 
TMRCA-labeled (red) copolymer altogether helped to 
visualize the process of endocytosis to C2C12 muscle cells 
and the nucleus localization of gene. 
 
  
II. RESULTS 
A. Loading of AON in polymer vesicles “polymersome” 
Degradable, self-porating polymer vesicles, 
polymersomes, were made with non-degradable and 
degradable copolymers. Upon the composition of polymer 
membrane, the releasing kinetics from vesicles could be 
programmed. Our group described this finding in the prior 
report [14]. Briefly, polyethylene oxide-poly butadiene 
makes inert, stable bilayer vesicle structures. The PEG-PBD 
vesicles are extremely stabilized and do not break over time 
[15]. This property was used for encapsulating small 
molecules like drug or dyes.  
To release their encapsulants, hydrolysable polyethylene 
oxide – poly lactic acid or polyethylene oxide – poly 
caprolactic acid was mixed to make bilayer polymer vesicles 
[14]. Blended polymer vesicles were good for encapsulating 
small molecular weight drugs and used for anti-cancer 
therapy [8]. In this study, antisense oligonucleotide could be 
loaded within polymer vesicles and released over the 
programmed time as in Fig. 1. 
The releasing kinetics of polymersomes, which were 
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TABLE I 
PHYSICAL PROPERTIES OF VARIOUS DIBLOCK COPOLYMERS 
Copolymer 
name 
FORMULA  
AM –BN 
Mn 
(kg/mol) P.D. wEO 
OB2 EO26-BD46 3.6 1.09 0.33 
OCL4 EO52-CL44 7.0 1.30 0.29 
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composed of 1:3 ratio of PEO-PBD and PEO-PCL were 
tuned for cell culture and animal studies. The releasing 
profiles of self-porating vesicles were examined at two 
conditions. For physiological conditions at 37 C, pH 7.4, 290 
mOsm, for acidic intercellular condition, at pH 5.5 were 
measured. The hydrolysis of PEO-PCL was accelerated in 
acidic condition, so the releasing time was shortened in the 
acidic condition [16]; half time for releasing was 4.5 hrs at 
pH 7.4 and 3.4 hrs at pH 5.5. The vesicles were stable at 4 C 
for 3 days with no significant release of AON. At low 
temperature, hydrolysis is extremely suppressed and 
rupturing of vesicle membrane progressed very slowly [17]. 
  
B. Uptake of non-degradable “ polymersomes”  by 
C2C12 myotubes 
Polymersomes can enter cells without targeting moieties 
because they have neutral pH and has poly ethylene glycol 
brushes on them. With long polyethylene oxide brushes on 
their surface, polymersomes have minimal cyto-toxicities and 
long circulation time in vivo [5]. F.Ahmed elucidated the 
cyto-toxicity and uptake mechanism of polymersomes [8]. 
To see the uptake by cells, especially muscle cells, 
well-defined muscle cell strips were used. On one separated 
muscle cell strips, the interaction of polymersome and cells 
could be observed easily, than in the interconnected and 
congested multi-nucleated myotubes. The well-defined 
patterns made it possible to distinguish between the 
polymersomes uptake of and non-specific binding to the 
glass surface. C2C12 myotubes grown on well-defined 
collagen coated IPN-patterns were used to study the cellular 
uptake and kinetics of non-degradable polymer, PEO-PBD.  
TMRCA conjugated polymers were mixed in polymersomes 
(1mg/ml initial concentration) to be added to the C2C12 
myotubes, and muscle cell patterns showed efficient uptake 
of polymeric vesicles in 1hr. The inert PEO-PBD vesicles 
showed punctated perinuclear localization within the 
myotube. Initially, punctuate distributions of internalized 
vesicles appeared throughout the cells with gradual 
accumulation in the perinuclear regions.  
 
Fig.   1.  Encapsulation and release of AON from polymersomes. 
(a) Bio-degradable AON (green) loaded vesicles, formed in DMSO-PBS
(15:85) using blended polymers PEO-PBD & PEO-PCL (1:3 w/w , red).
(b) Self-porating vesicles with PEO-PBD & PEO-PCL (1:3) show
sustained release of encapsulants, depending on temperature and pH.
Under slightly acidic conditions typical of endolysosomes, release is
accelerated. At 4oC, leakage over days is undetectable.  Inset:
Polymersomes sized down to 100 nm radiuses by sonication and extrusion
and measured by dynamic light scattering (DLS). 
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Fig.   2.   In vitro delivery of antisense oligonucleotide using 
biodegradable polymer vesicles.  
(a) Bright field image showing a single patterned myotube after delivery 
with no signs of apoptosis (left).  Fluorescent image of delivered AON in 
nuclei of the top-layer of the myotube (right). Scale bar is 10 microns (b) 
Delivery of AON in nuclei of myotubes grown in petri dish.  Overlay 
shows the AON transfected nuclei and blue (Hoechst dye) the total 
nuclei. (c) Delivery of non-degradable PEO-PBD vesicles. Patterned 
myotubes show punctated perinuclear delivery of AON-loaded Polymer
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C. In vitro Release and delivery of AON into C2C12 
myotubes 
Using degradable polymersome, encapsulated antisense 
could be delivered to nuclei. Polymersomes delivered 
antisense into cells and after certain time, polymer-shells 
were hydrolyzed and encapsulated antisense was released. 
The endolysomal delivery mechanism was suggested by 
Fariyal Ahmed using MC simulation [8].  
In the patterned IPN muscle cell strips, antisense were 
delivered into both of top layers and bottom layers. In figure 
2.a, the nucleus at upper part is nucleus located at the top 
layer and other nucleus is located at the bottom layer. 
Congested muscle cells in petri dish were also tested for 
delivery. The delivery was fairly comparable to PEI coupled 
antisense oligonucleotide. The transfection efficiency of 
polymer-loaded AON was comparable to PEI complexed 
AON, which was used as control.  Free AON did not show 
any significant nuclear delivery in myotubes grown in 
culture. 
 
D. Sub-cellular distribution of AON in nucleus 
After uptake of polymersomes by cells, polymersomes 
were located near nucleus and antisense was released and 
delivered to nucleus. In nucleus localization stage, antisense 
behavior was observed with pulse laser, which will exhaust 
the antisense fluorescence. High magnification images 
showed that antisense were stuck to some peculiar spots, and 
looked like antisense was not moving around any more. To 
confirm the mobility of antisense in nucleus, a milli-second 
pulse laser was shot for photo bleaching. This FRAP study 
gave some idea about where antisense is located at after 
delivery.  
FRAP study found that negatively charged antisense will 
be bound to somewhere in nucleus and rest of them will float 
freely around. In Figure 3, blue circle is background and pink 
circle is the fixed small spot. After few milli-seconds of 
photo bleaching, the fluorescence of blue and pink circles 
were completed (figure 3.2) the fluorescence intensity went 
down. The fluorescence was recovered in the certain time 
(figure 3.3). Although the background fluorescence was 
recovered almost up to the previous fluorescence level, the 
specific spot fluorescence did not come back as much. Only 
around 10% intensity levels came back on the pink spot, but 
more than 30% intensity levels were recovered in 
background, blue spot. 
 
E. In-vivo delivery of AON-polymersomes in mdx-mice by 
intramuscular injections: 
Dystrophin-defective mdx mice, which are DMD model 
mice, were used for intramuscular delivery, and the 
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Fig.   3.   Intranuclear delivery of fluorescent-AON.  
Magnified views of muscle nuclei showed a few discrete spots that are
likely concentrations at nuclear bodies. FRAP was conducted both on and
off of the spots.  The latter (red) showed quick and complete recovery of
fluorescence indicating high mobility, whereas the nuclear bodies (blue) 
showed little recovery.  
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Fig.   4. Intra muscular AON delivery in mdx mice.  
(a) Nuclear delivery of AON after release, shown in TA-muscle sections post 
12hrs injection. Fluorescent images show red-labeled biodegradable 
polymersomes (diffused), blue nuclei (total) and green AON (nuclei). (b)  
AON delivery in nuclei after 12hrs post injection of AON alone (no carrier) 
as control. 
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efficiency of delivery was observed. In 24 hrs of injection 
point, mice were sacrificed and TA muscles were pulled out 
to snap-freeze to see antisense delivery. The delivery 
efficiency was counted as the number of overlaid nuclei by 
green fluorescence by antisense and blue-fluorescence by 
nuclei. The red fluorescence in polymersomes did not bleed 
into green emission range. 
Also the efficiency of dystrophin restoration was tested. 
Initial experiments were performed in mdx mice 6–8 weeks 
(referred to as 6 weeks) of age with a single dose of 3 micro 
grams AON loaded in polymer vesicles. Three weeks after 
intramuscular injection, immunohistochemistry showed 
significant increases in the number of dystrophin-positive 
fibers in all skeletal muscles of the treated mice when 
compared with age-matched control mdx mice. However, the 
number of dystrophin-positive fibers varied between 
different areas of individual skeletal muscles and even 
between neighboring fibers. 
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